About
Lihan is the Founder and co-CEO of ark. In 2014, Lihan co-founded and served as CEO of MiRXES, a biotech startup developing microRNA technologies and cancer detection tests. He oversaw MiRXES’ operations in Singapore and China, and managed collaborations with leading clinical consortia and pharmaceutical companies in developing microRNA based diagnostic assays. MIRXES was recognized as Singapore’s Most Promising Startup 2016 by the Emerging Enterprise Award. Prior to founding MiRXES, Lihan was a research scientist at the Bioprocessing Technology Institute, A*STAR where he co-developed a novel microRNA qPCR assay platform and an integrated workflow for biomarker discovery. Lihan has a PhD in Biochemistry from the National University of Singapore. He has authored and co-authored more than 20 peer-reviewed publications and 8 patent applications. Lihan was recently recognized by the MIT Technology Review as a member of the Innovators Under 35.
Position in the VCSift Database
- • 3 investors at Mirxes are tracked.
- • 1 investors hold the Co-Founder, Director, and Chief Executive Officer role in VCSift. Zhou Lihan is one of them.
- • 1,940 investors are based in Singapore, Central Region, Singapore.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Singapore, Singapore
Contact Information
Find more investors like Zhou
Search Investors